These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23739513)

  • 1. [Developmental dysphasia in children: perspectives of neurotrophic therapy].
    Zavadenko NN; Kozlova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):43-7. PubMed ID: 23739513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potential of peptidergic nootropic therapy in developmental dysphasia in children].
    Zavadenko NN; Davydova LA; Suvorinova NY; Khondkaryan GS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(11):47-53. PubMed ID: 31851172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Developmental dysphasia: assessment of the drug treatment efficacy].
    Zavadenko NN; Kozlova EV; Koltunov IE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7 Pt 2):90-5. PubMed ID: 23330199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and electroencephalographic characteristics of specific language impairment in children and an evaluation of the efficacy of cerebrolysin].
    Chutko LS; Surushkina SY; Yakovenko EA; Sergeev AV; Rozhkova AV; Anosova LV; Chistyakova NP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):98-102. PubMed ID: 26356521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Developmental dysphasia in children: a comparison of the effectiveness of two modes of peptidergic nootropic therapy].
    Zavadenko NN; Davydova LA; Suvorinova NY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(10):38-44. PubMed ID: 33244956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of cerebrolysin on cognitive functions in childhood autism and in Asperger syndrome].
    Krasnoperova MG; Bashina VM; Skvortsov IA; Simashkova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(6):15-8. PubMed ID: 12872620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Speech disorders in children: early diagnosis and treatment].
    Zavadenko NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):119-125. PubMed ID: 28139638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental profiles in preschool children with autism spectrum disorders referred for intervention.
    Fernell E; Hedvall A; Norrelgen F; Eriksson M; Höglund-Carlsson L; Barnevik-Olsson M; Svensson L; Holm A; Westerlund J; Gillberg C
    Res Dev Disabil; 2010; 31(3):790-9. PubMed ID: 20207104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with Cerebrolysin.
    Molloy DW; Standish TI
    J Neural Transm Suppl; 2000; 59():293-300. PubMed ID: 10961441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of cerebrolysin in the treatment of ischemic stroke].
    Koppi S; Barolin GS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):30-3. PubMed ID: 9819885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological approaches to the therapy of Alzheimer's disease].
    Gavrilova SI
    Vestn Ross Akad Med Nauk; 2006; (9-10):30-4. PubMed ID: 17111921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuropsychological evaluation of long-term therapy of Alzheimer's disease using different cerebrolysin dosages].
    Roshchina IF; Gavrilova SI; Zharikov GA; Kalyn IaB; Kolykhalov IV; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):52-5. PubMed ID: 15704485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic efficacy of nootropil different doses in attention deficit hyperactivity disorder].
    Zavadenko NN; Suvorinova SIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(3):32-7. PubMed ID: 15071842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of cerebrolysin on the oxidant homeostasis, the content of microelements and electrolytes in children with minimal brain dysfunction].
    Gromova OA; Avdeenko TV; Burtsev EM; Skal'nyĭ AV; Solov'ev OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(1):27-30. PubMed ID: 9505400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial.
    Guekht AB; Moessler H; Novak PH; Gusev EI;
    J Stroke Cerebrovasc Dis; 2011; 20(4):310-8. PubMed ID: 20656516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The experience with endolumbar application of cerebrolysin in hemispheric ischemic stroke].
    Vilenskiĭ BS; Odinak MM; Shirokov EA; Vozniuk IA; Semenova GM; Grinevich TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(11):31-4. PubMed ID: 11247183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tactics of management of preschool children with different variants of speech delay].
    Lar'kina EV; Khaletskaia OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12):94-98. PubMed ID: 25726787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pathophysiological analysis of cerebrolysin therapy of children with mental developmental delay caused by ecological factors].
    Govorin NV; Zlova TP; Akhmetova VV; Tarasova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(5):51-5. PubMed ID: 18577958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial outcomes at 15 years of children with a preschool history of speech-language impairment.
    Snowling MJ; Bishop DV; Stothard SE; Chipchase B; Kaplan C
    J Child Psychol Psychiatry; 2006 Aug; 47(8):759-65. PubMed ID: 16898989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prelinguistic communication development in children with childhood apraxia of speech: a retrospective analysis.
    Highman C; Leitão S; Hennessey N; Piek J
    Int J Speech Lang Pathol; 2012 Feb; 14(1):35-47. PubMed ID: 22257070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.